20020611
 Celera Will Focus on Drug Discovery, Slash Jobs   By By Scott Hensley, The Wall Street Journal,  Jun 12, 2002  [Celera] shares fell $1.07, or 8%, to $12.07 in 4 p.m. New York Stock Exchange composite trading. The job cutbacks, Celera said, won't halt improvements to the genetic data that Celera sells online. Ms. [Kathy Ordonez] pointed to a project to sequence the DNA of 39 individuals and a chimp to pinpoint genetic variations of interest to scientists.   
